Getinge Group: Getinge Strengthens Competitiveness Through Concentration of
Production Units and Establishes Global Innovation Center
GETINGE, Sweden -- March 5, 2013
Getinge (STO:GETIB) continues to enhance its operational efficiency by further
concentrating its production to fewer units with greater resources. As a step
in this pursuit, the Extended Care business area intends to relocate the
manufacturing of its bath and hygiene products from Eslöv, Sweden, to the
production facility in Poznan, Poland, and to a third party.
The planned change will lead to the successive discontinuation of production
in Eslöv. All staff in Arjo Hospital Equipment in Eslöv and at Meditechnik in
Germany will be affected. About 150 employees in Eslöv and at Meditechnik are
expected to be made redundant, the majority in Sweden. The staff in Eslöv and
at Meditechnik was informed of the planned changes this morning.
“We will initiate discussions with the Swedish Public Employment Service and
the municipality to support the process of finding new employment for the
staff who are expected to be made redundant due to the planned discontinuation
of the operation in Eslöv,” says Alex Myers, Executive Vice President of
The discontinuation is scheduled to commence in mid-2013 and is expected to be
completed during the second half of 2014.
Getinge’s Extended Care business area, which operates under the ArjoHuntleigh
brand, will at the same time continue its intense focus on research and
development and on establishing a global innovation center in Malmö. The
center will concentrate on developing the company’s global range of mobility
and hygiene products, and will employ about 65 individuals. The center is
expected to open in spring 2013.
GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency in healthcare, care and
research. We operate under the three brands of ArjoHuntleigh, GETINGE and
MAQUET. ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control in healthcare and
contamination prevention in biotechnology. MAQUET specializes in solutions,
therapies and products for surgical interventions and intensive care.
The information is such that Getinge AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act.
This information was brought to you by Cision http://news.cision.com
CEO, Extended Care
Tel: +46 10335 46 53
Press spacebar to pause and continue. Press esc to stop.